I zoomed all the way out to the monthly chart to show the long-term support levels. We can see that HBIO is bouncing higher from a multi-year support level in the $2 range. The MACD (middle of the chart) didn't confirm an upward trend yet. However, the MACD did confirm the upward trend on the weekly chart. It looks like the blue monthly MACD line is close to...
even after its dramatic 1x from the 2022 low, still a buy... not sure another project in the top 100 mkt caps can give you a better possible return than FIL next BR. NFA.
Breaking through the double top barrier, HBIO is now gathering support around the previous resistance level. The stock has been in a steady accumulation stage with a strong uptrend and increasing volume. The strong uptrend should continue. The Benchmark Company has also changed their status from a Speculative Buy to a Buy, as of today. There is enough volume to...